Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond.
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
07
09
2020
revised:
27
10
2020
accepted:
12
11
2020
pubmed:
4
2
2021
medline:
19
3
2021
entrez:
3
2
2021
Statut:
ppublish
Résumé
Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2, a novel RNA virus that was declared a global pandemic on 11 March 2020. The efficiency of infection with SARS-CoV-2 is reflected by its rapid global spread. The SARS-CoV-2 pandemic has implications for patients with inflammatory skin diseases on systemic immunotherapy who may be at increased risk of infection or more severe infection. This position paper is a focused examination of current evidence considering the mechanisms of action of immunotherapeutic drugs in relation to immune response to SARS-CoV-2. We aim to provide practical guidance for dermatologists managing patients with inflammatory skin conditions on systemic therapies during the current pandemic and beyond. Considering the limited and rapidly evolving evidence, mechanisms of action of therapies, and current knowledge of SARS-CoV-2 infection, we propose that systemic immunotherapy can be continued, with special considerations for at risk patients or those presenting with symptoms.
Identifiants
pubmed: 33533553
doi: 10.1111/jdv.17075
pmc: PMC8014810
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
797-806Informations de copyright
© 2021 European Academy of Dermatology and Venereology.
Références
J Am Acad Dermatol. 2014 Dec;71(6):1167-75
pubmed: 25260564
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
J Invest Dermatol. 2018 Aug;138(8):1726-1735
pubmed: 29505759
Dermatol Ther. 2020 Jul;33(4):e13469
pubmed: 32347635
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Dermatol Ther. 2020 Jul;33(4):e13502
pubmed: 32362061
Nat Rev Immunol. 2020 Jun;20(6):345-346
pubmed: 32358580
J Dermatolog Treat. 2022 Feb;33(1):592
pubmed: 32403954
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
J Am Acad Dermatol. 2020 Jul;83(1):139-150
pubmed: 32213306
JAMA Dermatol. 2020 Jun 1;156(6):649-658
pubmed: 32267471
Clin Exp Rheumatol. 2013 Jul-Aug;31(4 Suppl 78):S63-70
pubmed: 24129141
Clin Rheumatol. 2019 Nov;38(11):2977-2994
pubmed: 31367943
Nat Rev Immunol. 2020 Jul;20(7):397-398
pubmed: 32457522
J Am Acad Dermatol. 2020 Aug;83(2):e151-e152
pubmed: 32376422
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Am Acad Dermatol. 2020 Jun;82(6):e223-e226
pubmed: 32278797
Australas J Dermatol. 2020 Aug;61(3):210-216
pubmed: 32255510
Br J Dermatol. 2014 Feb;170(2):435-44
pubmed: 24116868
Nat Rev Rheumatol. 2010 Mar;6(3):175-8
pubmed: 20197777
Nat Rev Drug Discov. 2016 May;15(5):327-47
pubmed: 26868298
J Eur Acad Dermatol Venereol. 2015 Jan;29(1):156-63
pubmed: 24684267
Dermatol Ther. 2020 Jul;33(4):e13554
pubmed: 32390177
J Am Acad Dermatol. 2020 Apr;82(4):1034
pubmed: 32081700
Rheumatology (Oxford). 2009 Aug;48(8):867-71
pubmed: 19447771
Autoimmun Rev. 2020 Jul;19(7):102567
pubmed: 32376392
Science. 2020 May 1;368(6490):473-474
pubmed: 32303591
Clin Exp Immunol. 2020 Nov;202(2):149-161
pubmed: 32671831
Arthritis Rheum. 2010 Jan;62(1):75-81
pubmed: 20039396
Research (Wash D C). 2020 Apr 19;2020:2402961
pubmed: 32377638
Lancet. 2017 May 20;389(10083):2031-2040
pubmed: 28342637
Antimicrob Agents Chemother. 2020 Jun 23;64(7):
pubmed: 32376613
Lupus. 2005;14 Suppl 1:s2-8
pubmed: 15803924
J Am Acad Dermatol. 2020 May;82(5):e173-e175
pubmed: 32224277
Sci Immunol. 2020 May 8;5(47):
pubmed: 32385052
Br J Dermatol. 2020 Aug;183(2):373-374
pubmed: 32343839
Arch Dermatol Res. 2015 Dec;307(10):875-83
pubmed: 26358263
J Gen Virol. 2013 Aug;94(Pt 8):1749-1760
pubmed: 23620378
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e241-e242
pubmed: 32223003
J Am Acad Dermatol. 2019 Apr;80(4):1029-1072
pubmed: 30772098
Virus Res. 2008 Apr;133(1):13-9
pubmed: 17374415
Nat Commun. 2020 Nov 12;11(1):5749
pubmed: 33184277
Lancet Rheumatol. 2020 May;2(5):e250-e253
pubmed: 32309814
Int J Rheum Dis. 2019 Aug;22(8):1361-1370
pubmed: 31099191
J Am Acad Dermatol. 2015 Jul;73(1):27-36.e1
pubmed: 25982539
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e295-e297
pubmed: 32302437
Virology. 2006 Sep 30;353(2):474-81
pubmed: 16860835
J Gen Virol. 2014 Mar;95(Pt 3):571-577
pubmed: 24323636
Gastroenterology. 2020 Aug;159(2):481-491.e3
pubmed: 32425234
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e249
pubmed: 32294282
Dermatol Ther. 2020 Sep;33(5):e13475
pubmed: 32356577
J Innate Immun. 2020;12(1):4-20
pubmed: 31610541
Nat Rev Immunol. 2020 Jun;20(6):355-362
pubmed: 32376901
Arthritis Res Ther. 2010;12(3):R111
pubmed: 20529331
Immunol Today. 1992 Apr;13(4):136-42
pubmed: 1374612
BMC Med. 2016 Sep 13;14(1):137
pubmed: 27623861
Acta Derm Venereol. 2008;88(5):495-501
pubmed: 18779890
J Gen Virol. 2011 Nov;92(Pt 11):2542-2548
pubmed: 21752960
Front Pharmacol. 2018 Oct 17;9:1048
pubmed: 30386231
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
Viruses. 2013 May 22;5(5):1250-60
pubmed: 23698397
Ecancermedicalscience. 2020 Mar 27;14:1022
pubmed: 32256705
Cytokine. 2018 Jan;101:56-63
pubmed: 27567553
Rheumatology (Oxford). 2007 Jul;46(7):1157-60
pubmed: 17478469
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Br J Dermatol. 1990 Jun;122 Suppl 36:47-56
pubmed: 2196084
Infect Dis Poverty. 2020 Mar 17;9(1):29
pubmed: 32183901
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
Cell Host Microbe. 2020 Mar 11;27(3):325-328
pubmed: 32035028
N Engl J Med. 2019 Feb 21;380(8):752-762
pubmed: 30415610
Int J Infect Dis. 2020 May;94:91-95
pubmed: 32173574
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510
N Engl J Med. 2020 Jul 2;383(1):85-88
pubmed: 32348641
J Am Acad Dermatol. 2019 Apr;80(4):904-912
pubmed: 30471316
Ann Intern Med. 2020 May 05;172(9):577-582
pubmed: 32150748
J Am Acad Dermatol. 2011 Dec;65(6):1135-44
pubmed: 21664719
J Leukoc Biol. 2019 Nov;106(5):1063-1068
pubmed: 31313387
Virol Sin. 2016 Feb;31(1):12-23
pubmed: 26786772
J Cutan Med Surg. 2016 Jul;20(4):313-6
pubmed: 26848145
Cell Mol Immunol. 2016 Jan;13(1):3-10
pubmed: 26189369
Am J Clin Dermatol. 2020 Jun;21(3):307-311
pubmed: 32277351
J Heart Lung Transplant. 2020 May;39(5):405-407
pubmed: 32362390
J Dermatolog Treat. 2020 Jun;31(4):317-318
pubmed: 32191143
Cell. 1991 Aug 23;66(4):807-15
pubmed: 1715244
J Med Virol. 2020 Apr;92(4):424-432
pubmed: 31981224
Exp Gerontol. 2018 May;105:4-9
pubmed: 29111233
J Clin Med. 2018 Dec 21;8(1):
pubmed: 30583473
Science. 2020 Apr 24;368(6489):356-360
pubmed: 32327580
Cytokine. 2019 Mar;115:13-23
pubmed: 30616034
Science. 2020 Aug 7;369(6504):718-724
pubmed: 32661059
Cardiovasc Res. 2020 Aug 1;116(10):1666-1687
pubmed: 32352535
Front Public Health. 2020 Apr 29;8:152
pubmed: 32411652
J Am Acad Dermatol. 2020 Jul;83(1):285-287
pubmed: 32330632
J Am Acad Dermatol. 2020 Jul;83(1):288-292
pubmed: 32380214
Cell Death Differ. 2020 May;27(5):1451-1454
pubmed: 32205856
J Am Acad Dermatol. 2020 May;82(5):1217-1218
pubmed: 32199889